Silencing of fragile X mental retardation 1 (FMR1) gene and loss of fragile X mental retardation protein (FMRP) cause fragile X syndrome (FXS), a genetic disorder characterized by intellectual disability and autistic behaviors. FMRP is an mRNA-binding protein regulating neuronal translation of target mRNAs. Abnormalities in actin-rich dendritic spines are major neuronal features in FXS, but the molecular mechanism and identity of FMRP targets mediating this phenotype remain largely unknown. Cytoplasmic FMR1 interacting protein 2 (Cyfip2) was identified as an interactor of FMRP, and its mRNA is a highly ranked FMRP target in mouse brain. Importantly, Cyfip2 is a component of WAVE regulatory complex, a key regulator of actin cytoskeleton, suggesting that Cyfip2 could be implicated in the dendritic spine phenotype of FXS. Here we generated and characterized Cyfip2 mutant 
INTRODUCTION
Fragile X syndrome (FXS) is the most common inherited cause of intellectual disability, accompanied by additional symptoms including autistic behaviors, increased susceptibility to seizures, craniofacial abnormalities and macroorchidism (1, 2) . The majority of FXS is caused by the expansion of CGG trinucleotide repeats (>200) in the 5' untranslated region of fragile X mental retardation 1 (FMR1) gene, which in turn results in transcriptional silencing of the gene and loss of fragile X mental retardation protein (FMRP) (3) (4) (5) (6) . FMRP is a polyribosome-associated mRNA-binding protein that is highly abundant in neurons and is involved in regulating the transport and translation of hundreds of target mRNAs (2, 7) .
Therefore, loss of regulation of target mRNAs is considered as the core molecular pathophysiology of FXS (7) .
Several forms of neuronal synaptic plasticity and function are altered in the mouse model of FXS (1) . Specifically, group1 metabotropic glutamate receptor (mGluR1 and mGluR5)-dependent long-term depression (LTD) is enhanced, and no longer requires new protein synthesis in the hippocampus of Fmr1 null mice (8, 9) . Moreover, genetic or pharmacological inhibition of mGluR in animal models of FXS rescues many of the FXSrelated phenotypes (1, 10) . Increased number of immature dendritic spines is also observed in the brains of Fmr1 null mice as well as FXS patients (11, 12) . The actin cytoskeleton is the structural basis of dendritic spines and is regulated by Rho family of small GTPases such as Cdc42, Rac1 and RhoA (13, 14) . FMRP has been associated with Rac1 signaling either by directly interacting with the protein components (p21-activated kinase and Cytoplasmic FMR1 interacting protein), or by regulating their mRNA translation (15) (16) (17) (18) . Furthermore, genetic or pharmacological inhibition of p21-activated kinase (PAK), a downstream effector of Rac1, rescues the dendritic spine phenotype and some of FXS-related behaviors in Fmr1 6 abundant in cortex followed by striatum and hippocampus, and least expressed in cerebellum (Fig. 1C) . Consistent with the mRNA expression pattern, endogenous Cyfip2 and WAVE proteins were detected in various brain regions with enrichment in the cortex and striatum (Fig. 1D) . In subcellular fractions, Cyfip2 was detected in both soluble cytosol (S2) and synaptic fraction (PSDI), while WAVE was more localized in synaptic fractions (P2 and PSDI) (Fig. 1D) .
In Cyfip2 +/-hippocampus and cortex, Cyfip2 mRNA levels were decreased by ~50%, but expression levels of Cyfip1 and Wave-1 mRNAs were not significantly changed (Fig. 1E ).
Hippocampal and cortical Cyfip2 protein levels were decreased to 50% and 70% of WT levels, respectively, in synaptosome of Cyfip2 +/-mice ( Fig. 1F) . Consistent with the role of Cyfip in WAVE stability (23) , WAVE protein level was also decreased in cortex, but not in hippocampus of Cyfip2 +/-mice (Fig. 1F ). This region-specific decrease of WAVE was not due to compensatory increase of Cyfip1 in hippocampus, as Cyfip1 levels were normal in both brain regions of Cyfip2 +/-mice (Fig. 1F ). It might suggest that WAVE stability is more dependent on Cyfip2 in cortex. In the open field test, Fmr1 -/y mice displayed increased locomotor activity ( Fig. 2A and B), as reported previously (31) . Interestingly, Cyfip2 +/-mice were also hyperactive compared to WT mice ( Fig. 2A and B) . Notably, in double mutant mice, the hyperactivity was significantly aggravated compared to Fmr1 -/y mice ( Fig. 2A) We compared the protein levels in whole lysates of hippocampus and whole brain from WT,
Cyfip2

+/-and Fmr1 -/y mice (8-week-old). Consistent with our previous result (Fig. 1F ),
Cyfip2 and WAVE levels were decreased in Cyfip2 +/-mice (Fig. 3A) . However, these proteins
were not altered in Fmr1 -/y mice (Fig. 3A) . We also prepared hippocampal and cortical synaptosome from Fmr1 -/y mice (8-week-old) and found that Cyfip2 and WAVE levels were normal (Fig. 3B) . We observed the same result from older (12- 5C ). However, in the cortex of double mutant mice, the densities of total protrusions and thin spines were further increased compared to Fmr1 -/y mice (Fig. 5D ). This cortex-specific enhancement of the dendritic spine phenotype in double mutant mice is consistent with the region-specific dendritic spine change in Cyfip2 +/-mice ( Fig. 5A and B). suggesting that new protein synthesis was required for the process (Fig. 6D ). This is consistent with the previous finding in hippocampal slice cultures where inhibition of protein synthesis blocked DHPG-induced spine change (37) .
mGluR-induced dendritic spine regulation and Cyfip2 expression are impaired in
Based on this result, we came back to the previous report that Cyfip2 mRNA is a high ranked FMRP target in mouse brain (28) . mGluR activation induces translation of FMRPassociated mRNAs and this process is impaired in Fmr1 null neurons (38, 39) . We hypothesized that mGluR activation could induce translation of Cyfip2 mRNA, which then might mediate mGluR-induced spine regulation. If our hypothesis is correct, this process should be impaired in both Fmr1 -/y and Cyfip2 +/-neurons, due to absence of the regulator or target mRNA, respectively (Fig. 6E) . We first tested whether DHPG treatment can increase Cyfip2 proteins in cultured WT cortical neurons. Indeed, 20 min DHPG incubation increased Cyfip2 proteins by 40% (Fig. 6F) . As positive controls, APP and PSD-95 proteins were also increased by DHPG treatment (Fig. 6F) (39, 40) . Pre-incubation of cycloheximide blocked the DHPG-induced Cyfip2 increase, suggesting its dependence on protein synthesis (Fig. 6F) . together with a previous study identifying Cyfip2 mRNA as a high ranked FMRP target in brain (28) , suggest that FMRP could be directly associated with Cyfip2 mRNA to regulate its mGluR-induced translation, and that Cyfip2 expression might be required for the mGluRinduced dendritic spine change.
Since we observed the increase of Cyfip2 proteins from whole neuronal lysates, it remains to be determined whether the mGluR-induced Cyfip2 synthesis occurred in neuronal dendrites. Notably, a recent study showed dendritic localization of Cyfip2 mRNAs (43) . Thus, it might be possible that FMRP regulates mGluR-induced dendritic transport and local translation of Cyfip2 mRNAs, as it does for other target mRNAs (38) . Visualization of both Cyfip2 mRNAs and proteins in neuronal dendrites before and after mGluR activation will be necessary to answer these questions. It is also not clear yet how acute Cyfip2 expression could contribute to the mGluR-induced spine regulation. One possible hypothesis is that the 
MATERIALS AND METHODS
Animals
Cyfip2
+/-mice were generated by injecting the ES cell (Cyfip2 tm1(KOMP)Vlcg ) purchased from UCDAVIS KOMP Repository. Cyfip2 +/-mice were maintained in C57BL/6J background. 
Biochemistry and antibodies
Mouse brain whole lysates, synaptosome and PSDI fraction were prepared as described previously (44) . Briefly, mouse brains were homogenized in buffered sucrose (0.32 M sucrose, 4 mM HEPES, 1 mM MgCl 2 , 0.5 mM CaCl 2 , pH 7.3) with freshly added protease inhibitors (Roche; 04693159001). The homogenate was centrifuged at 900 g for 10 min. The resulting supernatant was centrifuged again at 12,000 g for 15 min (the supernatant after this centrifuge is S2). The pellet was resuspended in buffered sucrose and centrifuged at 13,000 g for 15 min (the resulting pellet is P2; crude synaptosome). To obtain PSDI fractions, the synaptosomal fraction was extracted with with Triton X-100.
To analyze the molecular size of FMRP protein complex, mouse cortex was homogenized in extraction buffer (50 mM Tris pH 8.0, 75 mM NaCl, 0.5% Triton X-100, 30
mM EDTA plus protease and phophatase inhibitor cocktail) and centrifuged at 13,200 rpm for 10 min. The supernatant was transferred into new tube and centrifuged one more time.
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The resulting supernatant was spun over a 0.45 m microfuge spinfilter (Corning) at 6,000 rpm for 1 min, and applied to a Superose 6 10/300 GL column (GE Healthcare) using an Akta Purifier 10 system (GE Healthcare). The column was run with a flow rate of 0. The results were analyzed using the comparative Ct method normalized against the house keeping gene Gapdh as described previously (46) .
Behavioral assays
Behavioral assays were performed with 8 to 10-week-old animals as described previously Stimulation electrode was placed at the striatum radiatum to stimulate the Schaffer collateral pathway and fEPSPs of CA1 neurons were recorded with an ACSF-filled glass recording electrode (1-3 MΩ). Electrophysiological traces were amplified with AC-coupled amplifier (model 1800; A-M Systems), digitized using a Digidata 1320A, and acquired with pClamp software (Molecular Devices). The input-output relationship was used to estimate the general synaptic transmission properties of this pathway. Specifically, the rising slope of the fEPSP evoked by 100 μs pulses over various stimulus intensities (1V to 10V) was measured.
The stimulation intensity that evoked a fEPSP that had a slope of 30-35% of the maximum fEPSP slope determined by the input-output was used for measuring paired pulse ratio and long-term potentiation (LTP) formation. For long-term depression (LTD) formation, the stimulation strength that gave 50-60% of the maximal fEPSP slope was used. Recordings that did not exhibit stable fEPSP slope during the first 20 min of recording were excluded.
Paired pulse ratios were assessed via systematic variation of the inter-stimulus 60 µM cycloheximide (Sigma) were used to examine the contribution of protein synthesis for LTD formation.
Golgi staining
Standard Golgi-Cox impregnation using the FD Rapid Golgistain kit (NeuroTechnologies) was performed with serial sagittal brain sections (50 m). Images of dendritic spines on the secondary branches (apical dendrites of hippocampal CA1 and cortical layer II/III pyramidal neurons) were acquired by LSM710 (Zeiss) confocal microscope under DIC mode. Dendritic filopodia were defined as protrusions without head and having a length at least twice the width. Mature spines were defined as protrusions with heads and having a width greater than length. The rest of protrusions with heads were categorized as thin spines. The images were quantified in blind manner using ImageJ.
Neuron culture, transfection and immunostaining
Neuron culture, transfection and immunostaining were performed as described previously (47) . Neurons were transfected with pEGFP-C1 (empty vector) at days in vitro (DIV) 10, and fixed and immunostained at DIV 14. Antibodies used for immunostaining are FMRP (Millipore; MAB2160), GFP (Abcam; ab290) and VGlut1 (Synaptic Systems; 135 302).
(RS)-3,5-Dihydroxyphenylglycine (DHPG; Tocris) (100 M) was applied for 30 min before fixation. The images were quantified in blind manner using ImageJ. To measure DHPGinduced protein expression, cultured neurons (DIV 14) incubated with DHPG (100 M) were directly lysed with 2X Laemmli sample buffer for western blot analysis. Cycloheximide (60 M) was added to the media 30 min before and during DHPG treatment.
Statistical analysis
All data acquisition and analysis were carried out blinded to genotype. Statistical significance was determined by Student's t-test or ANOVA with Tukey's post hoc analysis using GraphPad Prism version 6. All data are presented as mean ± s.e.m. *P<0.05; **P<0.01; ***P<0.001.
SUPPLEMENTARY MATERIAL
Supplementary material includes three tables for the summary of statistical analyses.
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